September 1 ndi chiyambi cha mwezi wa lymphoma ndipo kuyambira lero mankhwala ena 2 atsopano awonjezedwa ku PBS kwa odwala lymphoma.
Nduna ya Zaumoyo ku Federal Greg Hunt posachedwapa yalengeza kuti kuyambira pa 1 Seputembala, odwala oyenerera aku Australia omwe ali ndi vuto loyambiranso / refractory primary mediastinal B cell lymphoma (PMBCL) ndi kuyambiranso / refractory Chronic Lymphocytic Leukemia (CLL) ndi Small Lymphocytic lymphoma (SLL) adzakhala ndi zatsopano. njira zochiritsira zomwe zilipo pa PBS.
PMBCL ndi mtundu wosowa kwambiri wa lymphoma ndipo odwala tsopano azitha kuwapeza Chinsinsi ngati ayambiranso kugwiritsa ntchito mankhwala am'mbuyomu kapena sanafune kulandira chithandizo. KEYTRUDA (Pembrolizumab) ndi mankhwala a immunotherapy omwe amathandizira chitetezo cha mthupi kulimbana ndi lymphoma.
Malangizo (Acalabrutinib) ipezekanso pa PBS kwa odwala oyenerera aku Australia omwe ali ndi Chronic Lymphocytic Leukemia ndi Small Lymphocytic Lymphoma. Ma lymphoma subtypes awa amawonedwa ngati khansa yosatha chifukwa simatha koma Calquence imapatsa odwala oyenerera njira yowonjezera yochizira.
Lymphoma Australia ikufuna kuthokoza odwala onse ndi anthu ena ammudzi omwe adatithandiza potumiza ku PBAC kotero kuti mankhwala atsopanowa adavomerezedwa kwa odwala onse oyenerera.
Kuti mumve zambiri komanso ndemanga zapa media, chonde imbani foni CEO wa Lymphoma Australia Sharon Winton pa 0431 483 204.
